texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x
Request an Appointment

Clinical Publications and Presentations

PUBLICATION TITLE
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
PUBLICATION
Journal of Clinical Oncology
CLINICIANS
Manish A. Shah, MD; Erin B. Kennedy, MHSc; Ashley E. Alarcon-Rozas, MD, MBA; Thierry Alcindor, MD; Angela N. Bartley, MD; Aubrey Belk Malowany; Asha Karippot, MD., et al.
PUBLICATION TITLE
What’s Driving the Rise of Colon Cancer in Young Adults?
PUBLICATION
ASCO
CLINICIANS
Asha Karippot, MD, FACP, and Aparna Parikh, MD
PUBLICATION TITLE
Geriatric Oncology Needs Assessment of an Interdisciplinary Oncology Team in a Collaborative Veteran’s Affairs Setting.
PUBLICATION
Journal of the American Geriatric Society
CLINICIANS
David J. Gregorio
PUBLICATION TITLE
Chapter 60 - Clinical Implication of Occult Systemic Micrometastatic Breast Cancer
PUBLICATION
The Breast, 6th Edition
CLINICIANS
Rozenblit M., Siddiq N., Pusztai, L.
PUBLICATION TITLE
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848
PUBLICATION
International Journal of Radiation Oncology, Biology, and Physics
CLINICIANS
Shivnani
PUBLICATION TITLE
Presentation, Diagnosis, and Management of the Li-Fraumeni Syndrome
PUBLICATION
Baylor University Medical Center Proceedings
CLINICIANS
Ogden, J; Pippen, J
PUBLICATION TITLE
Pre-Hospitalization Proton Pump Inhibitor Use and Clinical Outcomes in COVID-19
PUBLICATION
European Journal of Gastroenterology & Hepatology
CITATION
European Journal of Gastroenterology & Hepatology 34 (2), 137-141
CLINICIANS
P Ramachandran, A Perisetti, M Gajendran, F Jean-Louis, P Bansal
PUBLICATION TITLE
Red blood cell distribution width in hospitalized COVID-19 patients
PUBLICATION
Frontiers in Medicine
CITATION
Frontiers in Medicine 8, 582403
CLINICIANS
P Ramachandran, M Gajendran, A Perisetti, KO Elkholy, A Chakraborti,
PUBLICATION TITLE
Safety and Efficacy of First-Line Nivolumab Plus Ipilimumab Alternating With Nivolumab Monotherapy in Patients With Advanced Renal Cell Carcinoma: The Non-Randomised, Open-Label, Phase IIIb/IV CheckMate 920 Trial.
PUBLICATION
BMJ Open
CLINICIANS
PUBLICATION TITLE
Pembrolizumab Versus Placebo As Post-Nephrectomy Adjuvant Therapy for Clear Cell Renal Cell Carcinoma (KEYNOTE-564): 30-Month Follow-Up Analysis of a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial.
PUBLICATION
Lancet Oncology
CLINICIANS
Displaying results 1-10 (of 1745)
  < 1 2 3 4 5 6 7 8 9 10  > 

* Texas Oncology Clinicians